Table 2 Wilcoxon signed-rank test for paired samples (n = 383)
From: Multiple immunofluorescence assay identifies upregulation of Active β-catenin in prostate cancer
Marker | Normal expression Median [Q1; Q3] | Tumor expression Median [Q1; Q3] | p-value |
|---|---|---|---|
Nuclear Active β-catenin | 2.05 [0.00; 7.12] | 4.96 [0.46; 10.9] | < 0.001 |
Total Active β-catenin | 0.28 [0.13; 0.58] | 0.49 [0.20; 0.89] | < 0.001 |
HLA class I | 0.29 [0.10; 0.70] | 0.28 [0.16; 0.50] | 0.025 |